The A-share traditional Chinese medicine sector saw a surge, with Hainan Haiyao hitting the daily limit, followed by gains in other stocks such as Longshen Rongfa, Yibai Pharmaceutical, Keyuan Pharmaceutical, Changchun High & New Technology, Xinlicheng, and Xin Ganjiang.